PDB Short entry for 2A8H HEADER HYDROLASE 08-JUL-05 2A8H TITLE CRYSTAL STRUCTURE OF CATALYTIC DOMAIN OF TACE WITH THIOMORPHOLINE TITLE 2 SULFONAMIDE HYDROXAMATE INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: ADAM 17; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: CATALYTIC DOMAIN; COMPND 5 SYNONYM: A DISINTEGRIN AND METALLOPROTEINASE DOMAIN 17, TNF-ALPHA COMPND 6 CONVERTING ENZYME, TNF-ALPHA CONVERTASE, SNAKE VENOM-LIKE PROTEASE, COMPND 7 CD156B ANTIGEN; COMPND 8 EC: 3.4.24.86; COMPND 9 ENGINEERED: YES; COMPND 10 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: ADAM17, CSVP, TACE; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS TACE/ADAM-17, TACE-INHIBITOR COMPLEX, ZN-ENDOPEPTIDASE, HYDROLASE EXPDTA X-RAY DIFFRACTION AUTHOR J.I.LEVIN,J.M.CHEN,L.M.LAAKSO,M.DU,J.SCHMID,W.XU,T.CUMMONS,J.XU, AUTHOR 2 G.JIN,D.BARONE,J.S.SKOTNICKI REVDAT 5 23-AUG-23 2A8H 1 REMARK REVDAT 4 20-OCT-21 2A8H 1 REMARK SEQADV LINK REVDAT 3 24-FEB-09 2A8H 1 VERSN REVDAT 2 28-FEB-06 2A8H 1 JRNL REVDAT 1 07-FEB-06 2A8H 0 JRNL AUTH J.I.LEVIN,J.M.CHEN,L.M.LAAKSO,M.DU,J.SCHMID,W.XU,T.CUMMONS, JRNL AUTH 2 J.XU,G.JIN,D.BARONE,J.S.SKOTNICKI JRNL TITL ACETYLENIC TACE INHIBITORS. PART 3: THIOMORPHOLINE JRNL TITL 2 SULFONAMIDE HYDROXAMATES. JRNL REF BIOORG.MED.CHEM.LETT. V. 16 1605 2006 JRNL REFN ISSN 0960-894X JRNL PMID 16426848 JRNL DOI 10.1016/J.BMCL.2005.12.020 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH R.COWLING,D.BARONE,R.A.BLACK,J.S.SKOTNICKI REMARK 1 TITL ACETYLENIC TACE INHIBITORS. PART 2. SAR OF 6-MEMBERED CYCLIC REMARK 1 TITL 2 SULFONAMIDE HYDROXAMATES. REMARK 1 REF TO BE PUBLISHED REMARK 1 REFN REMARK 2 REMARK 2 RESOLUTION. 2.30 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0005 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.30 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 20.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.1 REMARK 3 NUMBER OF REFLECTIONS : 24593 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.218 REMARK 3 R VALUE (WORKING SET) : 0.215 REMARK 3 FREE R VALUE : 0.281 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 1313 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.30 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.36 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1689 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 96.40 REMARK 3 BIN R VALUE (WORKING SET) : 0.2210 REMARK 3 BIN FREE R VALUE SET COUNT : 105 REMARK 3 BIN FREE R VALUE : 0.2770 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4092 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 56 REMARK 3 SOLVENT ATOMS : 147 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 32.21 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 1.79000 REMARK 3 B22 (A**2) : -0.70000 REMARK 3 B33 (A**2) : -1.10000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.385 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.275 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.129 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 5.111 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.928 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.887 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 4250 ; 0.013 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 5747 ; 1.523 ; 1.968 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 514 ; 6.419 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 208 ;35.576 ;25.096 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 726 ;16.855 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 16 ;21.233 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 592 ; 0.141 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 3268 ; 0.005 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 2061 ; 0.216 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 2902 ; 0.304 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 264 ; 0.156 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): 3 ; 0.116 ; 0.200 REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 45 ; 0.175 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 15 ; 0.326 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 2653 ; 0.861 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 4115 ; 1.388 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1847 ; 1.793 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1632 ; 2.759 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : BABINET MODEL WITH MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 2A8H COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 15-JUL-05. REMARK 100 THE DEPOSITION ID IS D_1000033619. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 10-JAN-00 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.4 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ALS REMARK 200 BEAMLINE : 5.0.1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : GRAPHITE REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 4 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 31529 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.300 REMARK 200 RESOLUTION RANGE LOW (A) : 20.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.1 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : 0.05700 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.30 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.36 REMARK 200 COMPLETENESS FOR SHELL (%) : 96.4 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: 1BKC REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 42.50 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.20 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG 4000, ISOPROPANOL, NACITRATE, PH REMARK 280 5.4, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 292K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 24.18350 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 99.00550 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 29.60450 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 99.00550 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 24.18350 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 29.60450 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ARG A 215 REMARK 465 ALA A 216 REMARK 465 LYS A 476 REMARK 465 VAL A 477 REMARK 465 GLY A 478 REMARK 465 SER A 479 REMARK 465 HIS A 480 REMARK 465 HIS A 481 REMARK 465 HIS A 482 REMARK 465 HIS A 483 REMARK 465 HIS A 484 REMARK 465 HIS A 485 REMARK 465 ARG B 215 REMARK 465 ALA B 216 REMARK 465 ASP B 217 REMARK 465 ASN B 475 REMARK 465 LYS B 476 REMARK 465 VAL B 477 REMARK 465 GLY B 478 REMARK 465 SER B 479 REMARK 465 HIS B 480 REMARK 465 HIS B 481 REMARK 465 HIS B 482 REMARK 465 HIS B 483 REMARK 465 HIS B 484 REMARK 465 HIS B 485 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OG SER B 371 O LYS B 376 1.70 REMARK 500 SG CYS B 365 SG CYS B 469 2.03 REMARK 500 SG CYS B 225 SG CYS B 333 2.05 REMARK 500 SG CYS B 423 SG CYS B 453 2.07 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 PRO B 372 C - N - CD ANGL. DEV. = -16.7 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ALA A 270 -109.36 -134.05 REMARK 500 TRP A 312 164.42 -46.00 REMARK 500 MET A 345 38.55 39.33 REMARK 500 CYS A 365 124.90 93.19 REMARK 500 PRO B 220 -174.49 -57.11 REMARK 500 MET B 221 -25.58 63.46 REMARK 500 ASN B 269 16.94 50.82 REMARK 500 ALA B 270 -109.84 -130.23 REMARK 500 ALA B 358 41.21 -83.53 REMARK 500 ASN B 359 8.08 -155.46 REMARK 500 CYS B 365 116.72 77.36 REMARK 500 SER B 371 -41.19 141.86 REMARK 500 PRO B 372 98.34 -23.24 REMARK 500 VAL B 373 -62.19 -109.05 REMARK 500 LYS B 376 146.53 106.24 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 PRO B 372 VAL B 373 101.75 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN A 486 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 4NH A 158 O4 REMARK 620 2 4NH A 158 O5 82.4 REMARK 620 3 4NH A 158 N3 57.4 32.1 REMARK 620 4 HIS A 405 NE2 134.3 109.8 111.2 REMARK 620 5 HIS A 409 NE2 122.1 82.8 112.9 103.3 REMARK 620 6 HIS A 415 NE2 78.2 152.9 135.6 97.3 91.5 REMARK 620 N 1 2 3 4 5 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN B 486 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 4NH B 159 O5 REMARK 620 2 4NH B 159 O4 85.9 REMARK 620 3 4NH B 159 N3 32.6 58.6 REMARK 620 4 HIS B 405 NE2 107.9 126.0 108.2 REMARK 620 5 HIS B 409 NE2 77.0 130.2 108.2 103.8 REMARK 620 6 HIS B 415 NE2 154.2 74.3 132.8 97.2 103.1 REMARK 620 N 1 2 3 4 5 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ZN A 486 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ZN B 486 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 4NH A 158 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 4NH B 159 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1BKC RELATED DB: PDB REMARK 900 TACE CATALYTIC DOMAIN WITH TAPI REMARK 900 RELATED ID: 1ZXC RELATED DB: PDB REMARK 900 STRUCTURE OF TACE WITH DIFFERENT INHIBITOR DBREF 2A8H A 215 477 UNP P78536 ADA17_HUMAN 215 477 DBREF 2A8H B 215 477 UNP P78536 ADA17_HUMAN 215 477 SEQADV 2A8H ALA A 266 UNP P78536 SER 266 ENGINEERED MUTATION SEQADV 2A8H GLN A 452 UNP P78536 ASN 452 ENGINEERED MUTATION SEQADV 2A8H GLY A 478 UNP P78536 EXPRESSION TAG SEQADV 2A8H SER A 479 UNP P78536 EXPRESSION TAG SEQADV 2A8H HIS A 480 UNP P78536 EXPRESSION TAG SEQADV 2A8H HIS A 481 UNP P78536 EXPRESSION TAG SEQADV 2A8H HIS A 482 UNP P78536 EXPRESSION TAG SEQADV 2A8H HIS A 483 UNP P78536 EXPRESSION TAG SEQADV 2A8H HIS A 484 UNP P78536 EXPRESSION TAG SEQADV 2A8H HIS A 485 UNP P78536 EXPRESSION TAG SEQADV 2A8H ALA B 266 UNP P78536 SER 266 ENGINEERED MUTATION SEQADV 2A8H GLN B 452 UNP P78536 ASN 452 ENGINEERED MUTATION SEQADV 2A8H GLY B 478 UNP P78536 EXPRESSION TAG SEQADV 2A8H SER B 479 UNP P78536 EXPRESSION TAG SEQADV 2A8H HIS B 480 UNP P78536 EXPRESSION TAG SEQADV 2A8H HIS B 481 UNP P78536 EXPRESSION TAG SEQADV 2A8H HIS B 482 UNP P78536 EXPRESSION TAG SEQADV 2A8H HIS B 483 UNP P78536 EXPRESSION TAG SEQADV 2A8H HIS B 484 UNP P78536 EXPRESSION TAG SEQADV 2A8H HIS B 485 UNP P78536 EXPRESSION TAG SEQRES 1 A 271 ARG ALA ASP PRO ASP PRO MET LYS ASN THR CYS LYS LEU SEQRES 2 A 271 LEU VAL VAL ALA ASP HIS ARG PHE TYR ARG TYR MET GLY SEQRES 3 A 271 ARG GLY GLU GLU SER THR THR THR ASN TYR LEU ILE GLU SEQRES 4 A 271 LEU ILE ASP ARG VAL ASP ASP ILE TYR ARG ASN THR ALA SEQRES 5 A 271 TRP ASP ASN ALA GLY PHE LYS GLY TYR GLY ILE GLN ILE SEQRES 6 A 271 GLU GLN ILE ARG ILE LEU LYS SER PRO GLN GLU VAL LYS SEQRES 7 A 271 PRO GLY GLU LYS HIS TYR ASN MET ALA LYS SER TYR PRO SEQRES 8 A 271 ASN GLU GLU LYS ASP ALA TRP ASP VAL LYS MET LEU LEU SEQRES 9 A 271 GLU GLN PHE SER PHE ASP ILE ALA GLU GLU ALA SER LYS SEQRES 10 A 271 VAL CYS LEU ALA HIS LEU PHE THR TYR GLN ASP PHE ASP SEQRES 11 A 271 MET GLY THR LEU GLY LEU ALA TYR VAL GLY SER PRO ARG SEQRES 12 A 271 ALA ASN SER HIS GLY GLY VAL CYS PRO LYS ALA TYR TYR SEQRES 13 A 271 SER PRO VAL GLY LYS LYS ASN ILE TYR LEU ASN SER GLY SEQRES 14 A 271 LEU THR SER THR LYS ASN TYR GLY LYS THR ILE LEU THR SEQRES 15 A 271 LYS GLU ALA ASP LEU VAL THR THR HIS GLU LEU GLY HIS SEQRES 16 A 271 ASN PHE GLY ALA GLU HIS ASP PRO ASP GLY LEU ALA GLU SEQRES 17 A 271 CYS ALA PRO ASN GLU ASP GLN GLY GLY LYS TYR VAL MET SEQRES 18 A 271 TYR PRO ILE ALA VAL SER GLY ASP HIS GLU ASN ASN LYS SEQRES 19 A 271 MET PHE SER GLN CYS SER LYS GLN SER ILE TYR LYS THR SEQRES 20 A 271 ILE GLU SER LYS ALA GLN GLU CYS PHE GLN GLU ARG SER SEQRES 21 A 271 ASN LYS VAL GLY SER HIS HIS HIS HIS HIS HIS SEQRES 1 B 271 ARG ALA ASP PRO ASP PRO MET LYS ASN THR CYS LYS LEU SEQRES 2 B 271 LEU VAL VAL ALA ASP HIS ARG PHE TYR ARG TYR MET GLY SEQRES 3 B 271 ARG GLY GLU GLU SER THR THR THR ASN TYR LEU ILE GLU SEQRES 4 B 271 LEU ILE ASP ARG VAL ASP ASP ILE TYR ARG ASN THR ALA SEQRES 5 B 271 TRP ASP ASN ALA GLY PHE LYS GLY TYR GLY ILE GLN ILE SEQRES 6 B 271 GLU GLN ILE ARG ILE LEU LYS SER PRO GLN GLU VAL LYS SEQRES 7 B 271 PRO GLY GLU LYS HIS TYR ASN MET ALA LYS SER TYR PRO SEQRES 8 B 271 ASN GLU GLU LYS ASP ALA TRP ASP VAL LYS MET LEU LEU SEQRES 9 B 271 GLU GLN PHE SER PHE ASP ILE ALA GLU GLU ALA SER LYS SEQRES 10 B 271 VAL CYS LEU ALA HIS LEU PHE THR TYR GLN ASP PHE ASP SEQRES 11 B 271 MET GLY THR LEU GLY LEU ALA TYR VAL GLY SER PRO ARG SEQRES 12 B 271 ALA ASN SER HIS GLY GLY VAL CYS PRO LYS ALA TYR TYR SEQRES 13 B 271 SER PRO VAL GLY LYS LYS ASN ILE TYR LEU ASN SER GLY SEQRES 14 B 271 LEU THR SER THR LYS ASN TYR GLY LYS THR ILE LEU THR SEQRES 15 B 271 LYS GLU ALA ASP LEU VAL THR THR HIS GLU LEU GLY HIS SEQRES 16 B 271 ASN PHE GLY ALA GLU HIS ASP PRO ASP GLY LEU ALA GLU SEQRES 17 B 271 CYS ALA PRO ASN GLU ASP GLN GLY GLY LYS TYR VAL MET SEQRES 18 B 271 TYR PRO ILE ALA VAL SER GLY ASP HIS GLU ASN ASN LYS SEQRES 19 B 271 MET PHE SER GLN CYS SER LYS GLN SER ILE TYR LYS THR SEQRES 20 B 271 ILE GLU SER LYS ALA GLN GLU CYS PHE GLN GLU ARG SER SEQRES 21 B 271 ASN LYS VAL GLY SER HIS HIS HIS HIS HIS HIS HET ZN A 486 1 HET 4NH A 158 27 HET ZN B 486 1 HET 4NH B 159 27 HETNAM ZN ZINC ION HETNAM 4NH 4-({4-[(4-AMINOBUT-2-YNYL)OXY]PHENYL}SULFONYL)-N- HETNAM 2 4NH HYDROXY-2,2-DIMETHYLTHIOMORPHOLINE-3-CARBOXAMIDE FORMUL 3 ZN 2(ZN 2+) FORMUL 4 4NH 2(C17 H23 N3 O5 S2) FORMUL 7 HOH *147(H2 O) HELIX 1 1 ASP A 232 MET A 239 1 8 HELIX 2 2 GLU A 243 ASN A 264 1 22 HELIX 3 3 ASP A 313 ILE A 325 1 13 HELIX 4 4 ILE A 325 SER A 330 1 6 HELIX 5 5 PHE A 343 THR A 347 5 5 HELIX 6 6 LEU A 395 PHE A 411 1 17 HELIX 7 7 LEU A 420 ALA A 424 5 5 HELIX 8 8 ASN A 426 GLY A 430 5 5 HELIX 9 9 HIS A 444 MET A 449 5 6 HELIX 10 10 SER A 451 PHE A 470 1 20 HELIX 11 11 ASP B 232 MET B 239 1 8 HELIX 12 12 GLU B 243 ASN B 264 1 22 HELIX 13 13 ASP B 313 ILE B 325 1 13 HELIX 14 14 ILE B 325 SER B 330 1 6 HELIX 15 15 PHE B 343 THR B 347 5 5 HELIX 16 16 LEU B 395 PHE B 411 1 17 HELIX 17 17 LEU B 420 ALA B 424 5 5 HELIX 18 18 ASN B 426 GLY B 430 5 5 HELIX 19 19 HIS B 444 MET B 449 5 6 HELIX 20 20 SER B 451 PHE B 470 1 20 SHEET 1 A 5 GLY A 276 ILE A 284 0 SHEET 2 A 5 THR A 224 ALA A 231 1 N LEU A 227 O GLN A 278 SHEET 3 A 5 LEU A 334 THR A 339 1 O HIS A 336 N LEU A 228 SHEET 4 A 5 SER A 382 SER A 386 1 O THR A 385 N LEU A 337 SHEET 5 A 5 GLY A 349 ALA A 351 -1 N LEU A 350 O LEU A 384 SHEET 1 B 2 TYR A 369 SER A 371 0 SHEET 2 B 2 LYS A 376 ILE A 378 -1 O ILE A 378 N TYR A 369 SHEET 1 C 2 LYS A 388 ASN A 389 0 SHEET 2 C 2 LYS A 392 THR A 393 -1 O LYS A 392 N ASN A 389 SHEET 1 D 5 GLY B 276 ILE B 284 0 SHEET 2 D 5 THR B 224 ALA B 231 1 N VAL B 229 O ARG B 283 SHEET 3 D 5 LEU B 334 THR B 339 1 O PHE B 338 N VAL B 230 SHEET 4 D 5 SER B 382 SER B 386 1 O THR B 385 N THR B 339 SHEET 5 D 5 GLY B 349 ALA B 351 -1 N LEU B 350 O LEU B 384 SHEET 1 E 2 ALA B 368 TYR B 369 0 SHEET 2 E 2 ILE B 378 TYR B 379 -1 O ILE B 378 N TYR B 369 SHEET 1 F 2 LYS B 388 ASN B 389 0 SHEET 2 F 2 LYS B 392 THR B 393 -1 O LYS B 392 N ASN B 389 SSBOND 1 CYS A 225 CYS A 333 1555 1555 2.04 SSBOND 2 CYS A 365 CYS A 469 1555 1555 2.06 SSBOND 3 CYS A 423 CYS A 453 1555 1555 2.10 LINK O4 4NH A 158 ZN ZN A 486 1555 1555 2.11 LINK O5 4NH A 158 ZN ZN A 486 1555 1555 1.96 LINK N3 4NH A 158 ZN ZN A 486 1555 1555 2.60 LINK NE2 HIS A 405 ZN ZN A 486 1555 1555 2.10 LINK NE2 HIS A 409 ZN ZN A 486 1555 1555 2.16 LINK NE2 HIS A 415 ZN ZN A 486 1555 1555 1.86 LINK O5 4NH B 159 ZN ZN B 486 1555 1555 1.85 LINK O4 4NH B 159 ZN ZN B 486 1555 1555 2.09 LINK N3 4NH B 159 ZN ZN B 486 1555 1555 2.55 LINK NE2 HIS B 405 ZN ZN B 486 1555 1555 2.31 LINK NE2 HIS B 409 ZN ZN B 486 1555 1555 1.98 LINK NE2 HIS B 415 ZN ZN B 486 1555 1555 2.15 CISPEP 1 TYR A 304 PRO A 305 0 4.26 CISPEP 2 TYR B 304 PRO B 305 0 9.68 CISPEP 3 TYR B 370 SER B 371 0 -2.91 SITE 1 AC1 4 4NH A 158 HIS A 405 HIS A 409 HIS A 415 SITE 1 AC2 4 4NH B 159 HIS B 405 HIS B 409 HIS B 415 SITE 1 AC3 15 HOH A 120 THR A 347 LEU A 348 GLY A 349 SITE 2 AC3 15 LEU A 350 GLU A 398 LEU A 401 HIS A 405 SITE 3 AC3 15 GLU A 406 HIS A 409 HIS A 415 PRO A 437 SITE 4 AC3 15 ALA A 439 VAL A 440 ZN A 486 SITE 1 AC4 16 HOH B 116 GLY B 346 THR B 347 LEU B 348 SITE 2 AC4 16 GLY B 349 LEU B 350 LEU B 401 VAL B 402 SITE 3 AC4 16 HIS B 405 GLU B 406 HIS B 409 HIS B 415 SITE 4 AC4 16 PRO B 437 ALA B 439 VAL B 440 ZN B 486 CRYST1 48.367 59.209 198.011 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.020675 0.000000 0.000000 0.00000 SCALE2 0.000000 0.016889 0.000000 0.00000 SCALE3 0.000000 0.000000 0.005050 0.00000